Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC) - Episode 2

An Overview of the Molecular Characterization of Lung LCNEC

,

Panelists discuss how the characterization and classification of lung large cell neuroendocrine carcinoma (LCNEC) has evolved over the past decade, highlighting the clinical heterogeneity of these tumors and how it is navigated in clinical practice.

EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro
Now Viewing
EP. 2: An Overview of the Molecular Characterization of Lung LCNEC
EP. 3: The Pathological Diagnosis of Lung LCNEC
EP. 4: Biomarker Testing Strategies for Lung LCNEC
EP. 5: Biopsy Best Practices: Diagnosing Lung LCNEC
EP. 6: Lung LCNEC Diagnostic Challenges
EP. 7: A Multidisciplinary Approach to Managing Lung LCNEC
EP. 8: Lung LCNEC Disease Histology and Prognosis
EP. 9: The Role of DLL3 in LCNEC of the Lung
EP. 10: Insights on the LANCE Pilot Study on Lung LCNEC
  1. Dr. Dietrich to Dr. Yang:
  • How has the characterization and classification of lung LCNEC evolved in the past decade?
  • Can you describe the clinical heterogeneity of these tumors?
  • How do you navigate this in practice?

Related Content:

Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC)
Insights on the LANCE Pilot Study on Lung LCNEC
The Role of DLL3 in LCNEC of the Lung
Lung LCNEC Disease Histology and Prognosis